Rule of vitamin C in the treatment of idiopathic facial paralysis IFP (Bell's palsy)

Abbas Kinbar Kuser (1) , Redha Alwan Al-hashimi (2)
(1) College of Medicine, University of Misan, Iraq, Iraq ,
(2) College of Medicine, University of Misan, Iraq, Iraq

Abstract

This study was designed to show the rule of Vitamin C in the treatment of Bell's palsy when adding to the treatment of bell's palsy in compares to treatment without ascorbic acid and how its effect of fastening time of recovery. Six months from February to July 2019, and 60 patients were collected for this study, 22 patients treated with classical treatment for Bell's palsy, and on the other side 38 patients, we added Vitamin C (500mg) besides classical treatment for Bell's palsy. The results of the current study revealed that Patients with IFP were treated with vitamin C and classical treatments are gotten complete recovery within 4 weeks (92.1%) as compared to classical treatment alone (14.6%) with significant P value 0.0001. About complete resolution after4 to 6 weeks, there is no difference between both vitamin C and classical treatment (92.1%) and classical treatment alone (86.4%) with non-significant P-value. About facial residual, after 6 weeks, there is no difference between both vitamin C and classical treatment (10.5%) and classical treatment alone (10%) with non-significant P-value. It has been concluded that there is the significant value of vitamin C in the treatment of Bell's palsy as compares with classical treatment alone; but this positive value when treated early and good recovery in the first 4 weeks of IFP. A very good result in the hastening of the recovery period in the first 4 weeks but the same as a classical treatment alone after 4 weeks. In this study, no significant values of vitamin C to prevent complications of IFP.

Full text article

Generated from XML file

Authors

Abbas Kinbar Kuser
abaskk.mcm@uomisan.edu.iq (Primary Contact)
Redha Alwan Al-hashimi
Abbas Kinbar Kuser, & Redha Alwan Al-hashimi. (2019). Rule of vitamin C in the treatment of idiopathic facial paralysis IFP (Bell’s palsy). International Journal of Research in Pharmaceutical Sciences, 10(3), 2586–2590. Retrieved from https://ijrps.com/home/article/view/4172

Article Details

No Related Submission Found